BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

  March 31, 2025

   · 

  9 min read
• Press Releases

  Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

  March 31, 2025

   · 

  13 min read
• Press Releases

  Virion Therapeutics Reports Positive Clinical Data with VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure, at APASL 2025 Global Liver Meeting

  March 31, 2025

   · 

  6 min read
• Press Releases

  Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

  March 31, 2025

   · 

  15 min read
• Press Releases

  International Medication Systems, Ltd. Receives FDA’s Drug Shortage Assistance Award

  March 31, 2025

   · 

  5 min read
• Press Releases

  FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

  March 31, 2025

   · 

  8 min read
• Press Releases

  SINOVAC Announces New Board Member and Chairman of the Audit Committee

  March 31, 2025

   · 

  2 min read
• Press Releases

  Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

  March 31, 2025

   · 

  6 min read
• Press Releases

  Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

  March 31, 2025

   · 

  14 min read
• Press Releases

  Prolocor(R) Announces Publication in Circulation: Cardiovascular Interventions. Results Demonstrate That the Prolocor pFCG(TM) Test Predicts Risk of Subsequent Cardiovascular Events Regardless of Treatment Strategy (Percutaneous Coronary Intervention or Medical Management Alone)

  March 31, 2025

   · 

  4 min read